alks 4230,nemvaleukin alfa
alkermes
['nemvaleukin', 'artistry-6', 'melanoma']
 also in hall a at #asco23 is mark middleton's poster on artistry-6, a study on nemvaleukin alfa monotherapy in patients with advanced mucosal and cutaneous #melanoma: #crukfunded 
We're here to support our broad cancer research community of 4,000 scientists and clinicians. For general Cancer Research UK news & fundraising follow @CR_UK